BACK TO FUND'S DETAIL PAGE
All Holdings
All Holdings
211 Total Holdings:
As of 6/30/25
All Holdings:
1 -
15 of
211
| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets 
|
|---|---|---|---|---|
| Broadcom, Inc. | Equity | 8,828,667 | $2,433,622,059.00 | 6.25% |
| Capital Group Central Cash Fund | Short Term | 21,950,102 | $2,195,010,239.00 | 5.64% |
| Microsoft Corp. | Equity | 4,320,950 | $2,149,283,740.00 | 5.52% |
| NVIDIA Corp. | Equity | 10,316,245 | $1,629,863,548.00 | 4.19% |
| Amazon.com, Inc. | Equity | 6,675,768 | $1,464,596,742.00 | 3.76% |
| SK hynix, Inc. | Equity | 6,519,429 | $1,410,546,286.00 | 3.62% |
| Meta Platforms, Inc., Class A | Equity | 1,752,648 | $1,293,611,962.00 | 3.32% |
| Micron Technology, Inc. | Equity | 9,703,708 | $1,195,982,011.00 | 3.07% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | Equity | 30,170,000 | $1,094,762,426.00 | 2.81% |
| MercadoLibre, Inc. | Equity | 336,473 | $879,415,927.00 | 2.26% |
| Eli Lilly and Co. | Equity | 1,059,196 | $825,675,058.00 | 2.12% |
| Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) | Equity | 3,337,220 | $755,846,958.00 | 1.94% |
| Vertex Pharmaceuticals, Inc. | Equity | 1,318,424 | $586,962,365.00 | 1.51% |
| Alnylam Pharmaceuticals, Inc. | Equity | 1,532,833 | $499,841,513.00 | 1.28% |
| Airbus SE, non-registered shares | Equity | 2,330,752 | $486,668,980.00 | 1.25% |
All Holdings:
1 -
15 of
211